The role of c-jun protein in proliferation and apoptosis of the endometrium throughout the menstrual cycle

Gynecologic and Obstetric Investigation

Volumn 57, Issue 3, 2004, Pages 121-126

  Udou, Toshihiro ^a   Hachisuga, Toru ^a   Tsujioka, Hiroshi ^a   Kawarabayashi, Tatsuhiko ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

c Fos; c Jun; Endometrium, apoptosis proliferation; Ki 67; Menstrual cycle, endometrium

Indexed keywords

ANTIBODY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN C FOS; PROTEIN C JUN;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; APOPTOSIS; CELL DIVISION; CELL NUCLEUS; ENDOMETRIUM; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MENSTRUAL CYCLE; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ESTROGEN;

EID: 1642635065     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075701     Document Type: Article

References (20)

1. Vaskivuo TE, Stenbäck F, Karhumaa P, Risteli J, Dunkel L, Tapanainen JS: Apoptosis and apoptosis-related proteins in human endometrium. Mol Cell Endocrinol 2000;165:75-83.
2. von Rango U, Classen-Linke I, Krusche CA, Beier HM: The receptive endometrium is characterized by apoptosis in the glands. Hum Reprod 1998;13:3177-3189.
3. Matsumoto Y, Iwasaki T, Yamasaki F, Sugimori H: Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999;94:71-77.
4. Kokawa K, Shikone T, Nakano R: Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 1996;81:4144-4147.
5. Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP: Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod 2001;16:1802-1808.
6. Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Millar MR, Saunders PT: Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 2001;86:1370-1378.
7. Lecce G, Meduri G, Ancelin M, Bergeron C, Applanat MP: Presence of estrogen beta receptor in the human endometrium through the cycle: Expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab 2001;86:1379-1386.
8. Weihua Z, Saji S, Makinen S, Cheng G, Jensen EV, Warner M, Gustafsson JA: Estrogen receptor (ER) beta, a modulator of ERα in the uterus. Proc Natl Acad Sci USA 2000;97:5936-5941.
9. Matsuzaki S, Fukuya T, Suzuki T, Murakami T, Sasano H, Yajima A: Oestrogen receptor alpha and beta mRNA expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 1999;5:559-564.
10. Wisdom R, Johnson RS, Moore C: c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 1999;18:188-197.
11. Webb P, Lopez GN, Uht RM, Kushner PJ: Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995;9:443-456.
12. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson JA, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 1997;277:1508-1510.
13. Salmi A, Lintula HS, Rutanen EM: Cellular localization of c-jun messenger ribonucleic acid and protein and their relation to the proliferation marker Ki-67 in the human endometrium. J Clin Endocrinol Metab 1998;83:1788-1796.
14. Nephew KP, Choi CM, Polek TC, McBride R, Bigsby RM, Khan SA, Husseinzadeh N: Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue. Gynecol Oncol 2000;76:388-396.
15. Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T: Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometirum at the end of the secretory phase. J Clin Endocrinol Metab 1999;84:1737-1743.
16. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS Jr: Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988;67:334-340.
17. Bamberger AM, Bamberger CM, Gellersen B, Schulte HM: Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc Natl Acad Sci USA 1996;93:6169-6174.
18. Wang HG, Reed JC: Mechanisms of bcl-2 protein function. Histol Histopathol 1998;13:521-530.
19. Jones RK, Searle RF, Stewart JA, Turner S, Bulmer JN: Apoptosis, bcl-2 expression, and proliferative activity in human endometrial stroma and endometrial granulated lymphocytes. Biol Reprod 1998;58:995-1002.
20. Giudice LC, Mark SP, Irwin JC: Paracrine actions of insulin-like growth factors and IGF-binding protein-1 in non-pregnant human endometrium and at the decidual-trophoblast interface. J Reprod Immunol 1998;39:133-148.